Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prophylaxis of Neuropathic Pain by mémantine (MEMANTINE)

This study has been completed.
Sponsor:
Collaborator:
Dr Xavier DURANDO/Dr Marie-Ange MOURET/Dr Christine VILLATTE, Jean-Perrin Cancer Center, Clermont-Ferrand Hospital
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT01536314
First received: February 16, 2012
Last updated: June 30, 2014
Last verified: June 2014